Macrophages take up oxidized low density lipoprotein (oxLDL) in vitro, 2, 3) causing cholesterol accumulation. The fact that oxLDL is present in atherosclerotic lesions [4] [5] [6] has closed up the role of macrophage scavenger receptors to take up oxLDL in atherosclerosis. 2, 3) It is known that there are several types of scavenger receptor proteins on the macrophage surface that take up oxLDL: SR-A type (I, II 7, 8) and III 9) class and MARCO 10) ), CD36, 11) SR-BI, 12) CD68 (macrosialin), 13) LOX-1, 14) PSR 15) and SR-PSOX. 16) Several factors have been shown to stimulate or depress macrophage activity for oxLDL uptake. In the course of our studies it has been found that extracellular component fibronectin enhances the scavenger receptor activity of mouse macrophages through the receptors for fibronectin, 17) which is mediated by an increased Ca 2ϩ signaling pathway and inhibited by Ca channel blockers and calmodulin inhibitors. 18) In another study, it has been found that intracellular protein phosphorylation by myosin light chain kinase, protein kinase C and protein tyrosine kinase, and protein dephosphorylation by serine/threonine phosphatase and tyrosine phosphatase participate in the macrophage activity. 19) Inhibitors of protein kinases prevent, and inhibitors of protein phosphatase enhance, the macrophage binding of oxLDL and foam cell formation.
In the present study, we investigated other intracellular macrophage signals that enhance or inhibit the macrophage activity to bind and/or take up oxLDL. The arachidonic acid cascade, including phospholipase A 2 (PLA 2 ), cyclooxygenase and lipoxygenase to produce a series of eicosanoids with a variety of functions, 20, 21) is a candidate for the regulator of macrophage activity. It was found that inhibitors of arachidonic acid cascade inhibited the macrophage activity, and that arachidonic acid release caused by PLA 2 enhanced the macrophage activity. methylindocarbocyanine (DiI) perchlorate were obtained from Aldrich Chemical Company, Inc., Milwaukee, WI, U.S.A. [5,6,8,9,11,12,14,15- 3 H]Arachidonic acid ([ 3 H]arachidonic acid) (specific activity 210.0 Ci/mmol, 0.48 mM) was obtained from NEN, Boston, MA, U.S.A. Maleyl BSA was prepared according to the methods described elsewhere. 22, 23) Fibronectin was purified from pooled human plasma by affinity chromatography on gelatin-Sepharose 4B columns according to the method of Engvall and Ruoslahti, 24) with minor modifications as described previously. 25) The fibronectin concentration was determined spectrophotometrically using E (1%, 1 cm) at 280 nmϭ12.8.
26)
Coating of Culture Substrates with Fibronectin Each well of a 24-well plastic plate (15.5 mm diameter) or a round coverslip (15 mm diameter) placed in the well was loaded with 300 or 140 ml of a solution of fibronectin (100 mg/ml) in Ca 2ϩ , Mg 2ϩ -free Dulbecco's phosphate-buffered saline (DPBS (Ϫ)), respectively. After being left at room temperature for 12-24 h, the well or the coverslip was rinsed several times with Dulbecco's phosphate-buffered saline (DPBS) and used immediately.
Isolation and Oxidation of LDL LDL was isolated from fresh human plasma as described previously.
27) The LDL fraction obtained was dialyzed against DPBS (Ϫ), and subjected to Cu 2ϩ catalyzation. Briefly, LDL in DPBS (Ϫ) at 2.0 mg protein/ml was treated with 5 mM CuSO 4 at 37°C for 24 h. The reaction was terminated by addition of 50 mM butylated hydroxytoluene. The mixture was dialyzed against isotonic saline through which nitrogen gas had been bubbled, and stored at 4°C under nitrogen gas. The protein content in LDL was determined by the Lowry method 29) using BSA as a standard.
DiI-Acetyl LDL Acetyl-LDL was prepared according to the method described elsewhere, 30) by acetylating LDL (16 mg/ml) in saline with acetic anhydride. DiI-acetyl LDL was prepared according to the method of the preparation of DiI-LDL described elsewhere. 31) To a solution of acetyl LDL in saline was added DiI perchlorate at a LDL protein/DiI ratio of 100 : 15 (w/w), and the mixture was incubated at 37°C for 3 h under nitrogen atmosphere in the dark. Insoluble materials were removed by centrifugation at 1200ϫg for 20 min. A half amount of the 1.182 density solution for the isolation of LDL 27) was added to the solution, and the mixture was centrifuged at 115000ϫg at 16°C for 10 h. Red colored DiI-acetyl LDL on the surface was collected, dialyzed against saline and stored at 4°C for use.
Macrophages Macrophages were obtained from the peritoneal cavity of 7-12-week-old male ddY mice 4 d after the intraperitoneal injection of 2-3 ml of 3% thiogycollate medium. The peritoneal exudate cells obtained were washed twice with HBSS by centrifugation at 80ϫg and 4°C for 10 min, and then resuspended in RPMI-HEPES medium.
Uptake of oxLDL by Macrophages and Staining the Lipid Droplets within the Cells A 140 ml suspension of mouse macrophages (8.5ϫ10 5 cells/ml) was loaded onto a plain or fibronectin-coated coverslip (15-mm diameter), which was then incubated at 37°C for 1 h in a 5% CO 2 incubator. Non-adherent cells were removed by washing three times with DPBS (Ϫ), and the coverslip with macrophage monolayer was placed in each well of 24-well plastic plate (15.5 mm diameter). To the wells 0.5 ml of RPMI 1640 medium containing oxLDL (100 mg protein/ml), 5% heat-inactivated FCS, each of the inhibitors of arachidonic acid cascade at the indicated concentration and/or A23187 (0.1 nM) were added, and the plate was incubated at 37°C for 24 h. The macrophage monolayer was washed with DPBS (Ϫ), fixed with formalin, and neutral lipid droplets within the cells were stained with oil-red-O after which the nuclei were stained with Mayer's hematoxylin solution. The number of macrophages containing lipid droplets stained red was scored for the random fields of the coverslip. At least 200 cells were examined, and the percentage of positively stained cells was determined.
Determination of Cholesterol in Macrophages
The total cholesterol accumulation in macrophages was determined enzymatically according to a method described elsewhere.
32) The macrophage suspension (5ϫ10 5 cells/ml, 1 ml) was placed into a well of a 24 well plastic plate (15.5 mm diameter), and incubated at 37°C for 1 h in a CO 2 incubator. Nonadherent cells were removed by washing with DPBS (Ϫ). To the monolayer, 1.0 ml of RPMI medium containing 5% heat-inactivated FCS, 200 mg/ml of oxLDL and each of the inhibitors at the indicated concentration was placed, and the mixture was incubated at 37°C for 24 h in a CO 2 incubator. The monolayer was washed with DPBS (Ϫ). The cells were collected by use of a rubber-policeman, and the collected cells were washed with saline twice by centrifugation (2000ϫg, 10 min) at 4°C. To the cell pellet, 0.3 ml of 2-propanol was added, and the mixture was sonicated for 40 min to extract cholesterol. This mixture was centrifuged (800ϫg, 15 min). A 50 ml aliquot of the supernatant was used for free and total cholesterol determination. For free cholesterol determination, 400 ml of a mixture of cholesterol oxidase, horseradish peroxidase and p-hydroxyphenylacetic acid in sodium phosphate buffer (pH 7.0) was added, and for total cholesterol determination, 400 ml of a mixture of cholesterol ester hydrolase, cholesterol oxidase, horseradish oxidase, p-hydroxyphenylacetic acid, sodium taurocholate, and Carbowax-6000 in sodium phosphate buffer (pH 7.0) was added, and the mixture was incubated at 37°C for 40 min. After stopping the reaction by the addition of 0.5 M NaOH, cholesterol was determined by fluorometry. Protein in the residue of the 2-propanol extract was determined.
Binding and/or Uptake of DiI-Acetyl LDL by Macrophages A 1 ml suspension of mouse macrophages (5ϫ10 5 cells/ml) was loaded into each well of 24 well plastic plate (15.5 mm diameter), which was then incubated at 37°C for 1 h in a 5% CO 2 incubator. Nonadherent cells were removed by washing three times with DPBS (Ϫ). The macrophage monolayer was preincubated with 0.5 ml of RPMI-HEPES medium containing 5% BSA and each of the ligands/inhibitors at 37°C for 1 h in a CO 2 incubator. After removal of the solution, 0.5 ml of RPMI HEPES medium containing 1% BSA and DiI-acetyl LDL (50 mg/ml) was added, and the mixture was incubated at 37°C for 3 h. The well was washed five times with DPBS (Ϫ), and DiI-acetyl LDL was extracted with 1 ml of 2-propanol by sonication for 5 min. The extract was moved into a tube with a 1.5 ml capacity, and centrifuged at 18000ϫg for 5 min. The relative fluorescence intensity of the supernatant was determined at 524 nm (excitation) and at 567 nm (emission). Protein content in the macrophage was determined by dissolving another lot of the macrophage monolayer into 1 ml of 0.5 mM NaOH and by the Lowry method.
[ 3 H]Arachidonic Acid Incorporation into Macrophages and Its Release from Macrophages To a 1 ml suspension of macrophages in RPMI-HEPES medium containing 10% heat-inactivated FCS (5ϫ10 6 cells/ml), [ 3 H]arachidonic acid at 1850 Kbq (50 mCi) was added to make final concentration 1 mCi/ml. The mixture was incubated at 37°C for 12 h under gentle swirling. Macrophages were washed three times by centrifugation at 80ϫg for 10 min with RPMI-HEPES medium. The cells were resuspended in RPMI-HEPES medium to make 5ϫ10 5 cells/ml. A 1 ml cell suspension was placed in a plain or fibronectin-coated well, which was then incubated at 37°C for 3 h. Nonadherent cells were removed by washing with DPBS (Ϫ). To the monolayer, 0.5 ml of RPMI-HEPES medium containing each of the inhibitors was added, and the mixture was incubated at 37°C for 2 h. The medium (300 ml) was centrifuged at 8300ϫg for 1 min, and the radioactivity of 200 ml of the supernatant was measured. The remaining macrophage monolayer was solubilized by dissolving it into 0.5 ml of 2% SDS, and the protein content was determined by the Lowry method. The released radioactivity (dpm/mg macrophage protein) was calculated.
Macrophage Viability The viability of the cells was examined by the Trypan blue dye exclusion test. 33) A macrophage cell suspension (0.14 ml) was mixed with an equal volume of RPMI-HEPES medium containing a 2-fold excess amount of each of the inhibitors at the indicated concentrations in a siliconized tube, and the mixture was incubated at 37°C for 2 or 24 h in a CO 2 incubator. The mixture was then centrifuged (80ϫg, 10 min) at 4°C, and the pellet was resuspended in 50 ml of RPMI-HEPES medium. The viability of the cells was examined by Trypan blue dye.
RESULTS

Effect of Inhibitors of Arachidonic Acid Cascade on Foam Cell Formation and on Cholesterol Accumulation
The effect of arachidonic acid cascade inhibitors on the foam cell formation from macrophages and the cholesterol accumulation in contact with oxLDL was examined. In this assay, mouse macrophages obtained from thioglycollate-induced peritoneal exudate and oxLDL obtained by Cu 2ϩ -catalyzed oxidation were used, and the effect of the inhibitors on unstimulated, fibronectin-stimulated and Ca 2ϩ ionophore A23187 stimulated macrophages was examined. It has been shown that in fibronectin stimulated and A23187-stimulated macrophages, foam cell formation and cholesterol accumulation are enhanced through the Ca 2ϩ signaling pathway. 17, 18) Three kinds of arachidonic cascade inhibitors, PLA 2 inhibitors, dexamethasone 34) and quinacrine (mepacrine) 35, 36) ; cyclooxygenase inhibitors, indomethacin and aspirin 37) ; and lipoxygenase inhibitor AA861 38) were tested as arachidonic acid cascade inhibitors. When the unstimulated macrophage monolayer was incubated with oxLDL in the presence of these inhibitors, the inhibitors, except for dexamethasone, prevented the foam cell formation in dose-dependent fashions (Fig. 1A) . Foam cell formation from fibronectin-stimulated macrophages (Fig. 1B) , and from A23187-stimulated macrophages (Fig. 1C) were inhibited by all of these inhibitors.
The accumulation of free and total cholesterol in the unstimulated macrophages was reduced by incubation in the presence of these inhibitors (Fig. 2) . These results showed that the macrophage uptake of oxLDL and cholesterol accumulation in the cells were dependent on the arachidonic acid cascade pathway.
Decreased Arachidonic Acid Release Suppressed Macrophage Activity A simple and sensitive method for the macrophage activity to bind and/or take up oxLDL was developed to compare the macrophage activity and the arachidonic acid release from macrophages. Fluorescent DiI labeling, originally used for labeling native LDL, 31) was successfully applied to acetyl LDL instead of oxLDL. Unstimulated macrophage bound and/or took up DiI-acetyl LDL in a dose-dependent manner (Fig. 3A) . Binding and/or uptake of DiI-acetyl LDL was inhibited by the known polyanion ligands of scavenger receptors SR-A type (I and II class), poly I, 39, 40) dextran sulfate, 39, 40) fucoidan 39, 40) and maleyl BSA, 30, 39) but was not by a non-ligand poly C 39, 40) (Fig. 3B) , indicating that DiI-acetyl LDL was bound and/or taken up through the scavenger receptors SR-A type. Using this method, the effect of dexamethasone on the binding and/or uptake of DiI-acetyl LDL was examined (Fig. 3C ). Binding and/or uptake of DiIacetyl LDL by macrophages were inhibited by preincubation with dexamethasone in a dose-dependent fashion.
Under similar conditions whether arachidonic acid release in unstimulated macrophages was inhibited by PLA 2 inhibitors was examined. The release of radioactivity from [ 3 H]arachidonic acid-labeled macrophages was inhibited during the 2 h incubation in the presence of quinacrine (Fig.  4A) . The release was inhibited in the subsequent 2 h-incubation after the removal of the inhibitors from the 2 h-incuba- A: The macrophage monolayer was incubated at 37°C for 3 h with DiI-acetyl LDL at the indicated concentration. Incorporated or bound DiI acetyl LDL was extracted with 2-propanol, and the relative fluorescence intensity was determined. B: The macrophage monolayer was preincubated with the ligand of scavenger receptors at 37°C for 1 h, then incubated with DiI-acetyl LDL at 37°C for 3 h. Results are expressed in comparison to the value in the absence of the ligands being 100 (corresponding to 0.72 mg LDL/mg macrophage protein). C: The macrophage monolayer was preincubated with dexamethasone at 37°C for 1 h, and then incubated with DiI-acetyl LDL at 37°C for 3 h. Results are expressed in comparison to the value in the absence of dexamethasone being 100 (corresponding to 0.42 mg LDL/mg macrophage protein). Data are presented as meanϮS.D. of triplicate determinations. tion mixtures with dexamethasone and quinacrine (Fig. 4B) . Hence, under the conditions where DiI-acetyl LDL binding and/or uptake was inhibited by dexamethasone (Fig. 3C) , the release of arachidonic acid was inhibited by the PLA 2 inhibitors. These results indicate that the inhibition of arachidonic acid release caused the supression of the scavenger receptor activity.
Increased Arachidonic Acid Release Enhanced Macrophage Activity Exogenous PLA 2 derived from bee venom and Crotalus adamanteous venom 41) is known to release arachidonic acid from cell membranes. The effect of exogenously added PLA 2 on the scavenger receptor activity of unstimulated macrophages was examined. When [ 3 H]arachidonic acid labeled macrophages were incubated with bee venom PLA 2 , the release of arachidonic acid was extensively increased (Fig. 5A ). When the macrophages were incubated with Crotalus adamanteous venom, the release was slightly increased (Fig. 5B) . Macrophage binding and/or uptake of DiI-acetyl LDL after preincubation with PLA 2 was slightly increased with an optimal concentration of PLA 2 (Fig. 6 ). Foam cell formation in the incubation of macrophages and oxLDL in the presence of PLA 2 , was extensively enhanced (Fig. 7) .
Effect of Inhibitors of Protein Phosphorylation on Arachidonic Acid Release and Macrophage Activity
An inhibitor of myosin light chain kinase, ML-9, 42) and an inhibitor of protein kinase C, staurosporine, 43) have been shown to inhibit macrophage activity in oxLDL binding and foam cell formation. 19) Although the protein kinase inhibitors prevented the macrophage binding and/or uptake of DiIacetyl LDL (Fig, 8A) , they did not inhibit arachidonic acid release under similar conditions (Fig. 8B) . It is likely that cytosolic PLA 2a , which is activated by phosphorylation, 44) was not involved, but the secretary or Ca was involved in the macrophage activation.
Effect of Nordihydroguaiaretic Acid on Arachidonic Acid Release and Macrophage Activity Phenolic antioxidant nordihydroguaiaretic acid (NDGA) has been shown to inhibit macrophage activity. 46) On the other hand, NDGA is known to inhibit PLA 2 , 47, 48) cyclooxygenase and lipoxygenase. [49] [50] [51] [52] Effects of NDGA on arachidonic acid release from unstimulated macrophages and on DiI-acetyl LDL binding and/or uptake of macrophages were examined (Fig.   9 ). It was found that NDGA significantly inhibited both DiIacetyl LDL binding and/or uptake and arachidonic acid release. Hence, the preventive effect of NDGA on macrophage activity 46) may be due partly to the prevention of the arachidonic acid cascade.
Effect of Fibronectin on Arachidonic Acid Release The effect of fibronectin on arachidonic acid release from macrophages was examined. Release of radioactivity from [ 3 H]arachidonic acid-labeled macrophages was examined on fibronectin stimulation. It was found that the release was not affected in either the absence or presence of FCS by fibronectin stimulation (Fig. 10) , indicating that fibronectinstimulation of macrophage activity through Ca 2ϩ influx 18) may not be involved in the activation of PLA 2 . It is likely that Ca 2ϩ -independent PLA 2 45) participated in the macrophage activation through the arachidonic acid cascade.
DISCUSSION
Several factors have been shown to stimulate or depress macrophage scavenger receptors for oxLDL uptake. Unidentified serum factors, 53) monocyte colony-stimulating factor, 54, 55) a platelet-derived factor 56) and dexamethasone 57) have been reported to enhance the uptake of oxLDL and other ligands for scavenger receptors. Lymphocyte-conditioned medium, 58, 59) interferon, 60) tumor necrosis factor, 61) transforming growth factor 62) and some macrophage-stimulating agents 63) have been shown to suppress the receptor activity. In the course of our studies, three methods of activation of macrophages have been demonstrated: fibronectin-stimulation by Ca 2ϩ influx, 17, 18) protein phosphorylation-induced enhancement, 19) and oxidative stress-induced enhancement (probably through protein phosphorylation). 64 ) Extracellular component fibronectin stimulates the scavenger receptor activity of mouse macrophages through the receptors for fibronectin, 17) and this activation is then is mediated by the increased Ca 2ϩ signaling pathway. 18) The fibronectin-stimulation of the ability of the macrophages to bind and take up oxLDL is canceled by Ca 2ϩ channel blockers and calmodulin inhibitors, and the stimulation is similarly induced by a Ca 2ϩ ionophore, A23187. The Ca 2ϩ channel blockers and the calmodulin inhibitors appeared to inhibit the enhancing effect of fibronectin since these inhibitors did not inhibit the binding and/or uptake activity of the unstimulated macrophages. The number of scavenger receptors is increased by fibronectin-stimulation, which may not be due to de novo synthesis of the receptor protein, but to increased transport of the cytoplasmic receptor pool to the cell surface, or redistribution of scavenger receptors from the cell attachment side to the apical surface of the cell. 18) In another study, we found that intracellular protein phosphorylation is involved in the maintenance or the enhancement of the scavenger receptor activity of mouse macrophages. 19) Treatment of macrophages with inhibitors of myosin light chain kinase, protein kinase C and protein tyrosine kinase inhibit the macrophage binding to oxLDL, macrophage foam cell formation and the whole intracellular phosphorylation. Treatment of macrophages with inhibitors of protein serine/threonine phosphatase and protein tyrosine phosphatase enhanced the macrophage binding activity to oxLDL, macrophage foam cell formation and the whole intracellular phosphorylation. The protein kinase inhibitors reduced the fibronectin-stimulated macrophage activity. Moreover, the activity of macrophages to bind oxLDL and subsequent foam cell formation are decreased by a wide variety of different types of antioxidants, lipid-soluble chain breaking phenolic antioxidants, water-soluble phenolic antioxidants, water-soluble glutathione-related antioxidants, and water-soluble ascorbic acid-related antioxidants. 46) Cholesterol accumulation in macrophages induced by oxLDL is also prevented by lipid-soluble and water-soluble phenolic antioxidants. In addition to protein kinase inhibitors, most antioxidants prevented total protein phosphorylation and protein tyrosine phosphorylation of mouse macrophages. 64) Activity of the macrophages may be maintained by protein phosphorylation under oxidative stress, which may be prevented by antioxidants. Oxidative stress in macrophages may be important for maintainining the macrophage activity.
In the present study, it was found that the arachidonic acid cascade, including PLA 2 , cyclooxygenase and lipoxygenase, stimulated the activity of macrophages, and arachidonic acid release caused by PLA 2 may play an important role in the enhancement of the macrophage activity. Although the previous report has demonstrated that dexamethasone, a PLA 2 inhibitor, enhances scavenger receptor activity, 57) the present results showed that the agent was suppressive. All the known arachidonic acid cascade inhibitors were suppressive against macrophage activity in foam cell formation (Fig. 1) and cholesterol accumulation (Fig. 2) . Moreover, exogenously added PLA 2 enhanced oxLDL binding to macrophages and foam cell formation (Figs. 6, 7) .
Among the first key enzyme of the arachidonic acid cascade, only cytosolic PLA 2 is known to be activated by phosphorylation.
44) The present results showed that the inhibitor of protein kinase C did not prevent arachidonic acid release from macrophages (Fig. 9) , indicating that cytosolic PLA 2 phosphorylation did not participate in the arachidonic acid cascade in the macrophage activation.
Antioxidant NDGA, an inhibitor of PLA 2 , cyclooxygenase and lipoxygenase, [47] [48] [49] [50] [51] [52] prevented both arachidonic acid release and the scavenger receptor activity. This reagent has been shown to inhibit the macrophage activity for oxLDL, 46) and to suppress intracellular protein phosphorylation of macrophages in another studies. 64) The suppressing activity of NDGA for the macrophage activity may be due to the inhibition of both protein phosphorylation and the arachidonic acid cascade. While foam cell formation of fibronectin-stimulated or Ca ionophore stimulated macrophages, as well as unstimulated macrophages, was prevented by the arachidonic acid cascade inhibitors (Fig. 1) , fibronectin-stimulation did not cause increased arachidonic acid release under the conditions in the present study (Fig. 10) . Although it is shown that Ca 2ϩ influx stimulates arachidonic acid release of macrophages, 65, 66) the present results imply that fibronectinstimulation of macrophages related to Ca 2ϩ influx was independent from the arachidonic acid cascade.
In the present study, a simple and sensitive fluorescence method for the scavenger receptor (SR-type A) activity to bind and/or take up oxLDL was newly developed. Fluorescent DiI labeling originally used for labeling native LDL 31) was successfully applied to acetyl LDL, whereas this labeling was unsuccessful for oxLDL. DiI-acetyl LDL was bound and/or taken up into macrophages in a dose-dependent manner, as assessed by fluorescence measurement of the extract of the cells. Because binding and/or uptake of DiI-acetyl LDL was inhibited by the known polyanion ligands of SR-A type (I and II class) scavenger receptors, DiI-acetyl LDL was bound and/or taken up through the scavenger receptors. By using this method, binding and/or uptake of oxLDL to macrophages through scavenger receptors could be readily measured.
